3,015
Views
72
CrossRef citations to date
0
Altmetric
Review

The Discovery and Development of a Novel Vaccine to Protect against Neisseria meningitidis Serogroup B Disease

, , , , , , , , , & show all
Pages 5-13 | Received 24 Jul 2014, Accepted 29 Jul 2014, Published online: 01 Nov 2014
 

Abstract

Vaccines have had a major impact on the reduction of many diseases globally. Vaccines targeted against invasive meningococcal disease (IMD) due to serogroups A, C, W, and Y are used to prevent these diseases. Until recently no vaccine had been identified that could confer broad protection against Neisseria meningitidis serogroup B (MnB). MnB causes IMD in the very young, adolescents and young adults and thus represents a significant unmet medical need. In this brief review, we describe the discovery and development of a vaccine that has the potential for broad protection against this devastating disease.

Disclosure of Potential Conflicts of Interest

All authors are employed by Pfizer and as such may own Pfizer stock.

Acknowledgements

The authors would like to thank Julia Li, Han-Qing Jiang, Kathryn Mason, Lynn Miller, Christine Stokes, Jennifer Obregon, and Deanne Illenberger for technical support; all are employees of Pfizer. The authors also thank Michael Pride, Shite Sebastian, Robert Donald, also employees of Pfizer for their insightful comments associated with this work. This work was funded by Pfizer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.